Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA (Bevacizumab Biosimilar) in Indonesia Read more
TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases Read more
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy Read more
Aruvant Chooses Lonza to Manufacture ARU-1801, a Potentially Curative Treatment for Sickle Cell Disease, for Pivotal Trial Read more
Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records Read more
Pfizer’s XALKORI (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults Read more
Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer Read more
Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU) Read more